Anamay Biotech

Anamay Therapeutics is a biotechnology company focused on the discovery and development of small molecule drugs that target RNA to treat diseases with high unmet medical needs. By leveraging a proprietary platform that integrates structural biology and medicinal chemistry, the company identifies small molecules capable of modulating RNA function, potentially addressing targets previously considered undruggable. Anamay's research is primarily centered on oncology and rare genetic disorders where RNA dysregulation plays a critical role. Founded by industry veterans with deep expertise in RNA biology, the company aims to create a new class of precision medicines that act at the transcript level.